The Heart/X
Jul 14, 2025, 12:30
The Heart: Managing Warfarin-Induced Coagulopathy – New Insights into Handling Prolonged INR Levels
The Heart has published on its official X page:
“Management of Prolonged INR (Warfarin-Induced Coagulopathy)”
Effective management of warfarin-induced coagulopathy, characterized by prolonged INR, is crucial to mitigate bleeding risks. Recent updates highlight evidence-based strategies for timely INR reversal, emphasizing a balance between anticoagulation control and patient safety.
More detailed insights on this topic are available at Hemostasis Today.
American Society of Hematology
American Thrombosis and Hemostasis Network
Anticoagulant complications
Bleeding risk reduction
Coagulopathy guidelines
EHA
Emergency anticoagulation care
Hemostasis and Thrombosis Research Society
Hemostasis management
Hemostasis Today
INR reversal strategies
Prolonged INR management
The Heart
Vitamin K antagonists
Warfarin safety
Warfarin-induced coagulopathy
World Federation of Hemophilia
-
Jul 23, 2026, 08:27Registration Is Now Open for ASH 2026
-
Jul 23, 2026, 08:19Sheeza Nawaz: Why Do Patients With Aortic Stenosis Bleed?
-
Jul 23, 2026, 07:59Paschalis Karakasis: Can Left Atrial Appendage Closure Truly Replace Oral Anticoagulation?
-
Jul 23, 2026, 06:53Lakmali Silva: What Makes ISTH More Than a Scientific Meeting?
-
Jul 23, 2026, 05:48Paschalis Evangelidis: Rethinking Pulmonary Embolism Through the Lens of Thromboinflammation
-
Jul 23, 2026, 05:35Neil Morgan: Honoured to Lead the Platelet and Megakaryocyte Theme at ISTH 2026
-
Jul 23, 2026, 04:42Camilla Oriani: A Memorable First ISTH 2026 in Paris
-
Jul 23, 2026, 03:32Nazlı Pelin Kirkayak: A 9-Year Real-World Analysis of Adult Thrombotic Microangiopathies
-
Jul 23, 2026, 03:24Christelle Orlando: Driving Progress Through Science and Collaboration at ISTH 2026